Soleus Capital Management, L.P. Tandem Diabetes Care Inc Transaction History

Soleus Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$35.86 - $46.5 $3.92 Million - $5.08 Million	-109,200 Reduced 34.94%	203,300 $8.26 Million
Q4 2022 Feb 14, 2023	SELL	$35.49 - $56.15 $3.64 Million - $5.77 Million	-102,700 Reduced 24.74%	312,500 $14 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $68.97 $10.1 Million - $16 Million	231,400 Added 125.9%	415,200 $19.9 Million
Q2 2022 Aug 15, 2022	BUY	$53.22 - $123.09 $9.78 Million - $22.6 Million	183,800 New	183,800 $10.9 Million
Q1 2020 May 15, 2020	SELL	$47.37 - $90.04 $360,012 - $684,304	-7,600 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$53.13 - $71.19 $403,788 - $541,044	7,600 New	7,600 $453,000

354

71.9M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.28B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.